Antineutrophil cytoplasmic antibody-associated glomerulonephritis in Taiwanese

Nephrology

Volumn 9, Issue 5, 2004, Pages 297-303

  Hung, Peir Haur ^a   Chiang, Wen Chih ^b   Chen, Yung Ming ^b   Lin, Shuei Liong ^b   Lin, Wei Chou ^b   Tsai, Tun Jun ^b   Chen, Wan Yu ^b  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antineutrophil cytoplasmic antibodies; Glomerulonephritis; Taiwan

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMOPTYSIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; LUNG INFILTRATE; LUNG INJURY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; NEPHRITIS; OUTCOMES RESEARCH; PAUCI IMMUNE NECROTIZING CRESCENTIC GLOMERULONEPHRITIS; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; SEIZURE; SEPSIS; SURVIVAL RATE; SYSTEMIC VASCULITIS; TAIWAN; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TAIWAN;

EID: 9644289385     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00268.x     Document Type: Article

References (32)

1. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int. 1994; 46: 1-15.
2. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J. Am. Soc. Nephrol. 1997; 8: 314-22.
3. Nölle B, Specks U, Lüdemann G et al. Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann. Intern. Med. 1989; 111: 28-40.
4. Tesar V, Rihova Z, Jancova E, Rysava R, Merta M. European randomized trials: Current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials. Nephrol. Dial. Transplant. 2003; 18 (Suppl. 5): 2-4.
5. Franssen CF, Gans RO, Arends B et al. Differences between antimyeloperoxidase and anti-proteinase 3-associated renal disease. Kidney Int. 1995; 47: 193-9.
6. Gans RO, Kuizinga MC, Goldschmeding R et alt. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 1993; 64: 182-8.
7. Hattori M, Kurayama H, Koitabashi Y. Japanese society for pediatric nephrology. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J. Am. Soc. Nephrol. 2001; 12: 1493-500.
8. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J. Am. Soc. Nephrol. 1996; 7: 23-32.
9. Hauer HA, Bajema IM, Van Houwelingen HC et al. European Vasculitis Study Group (EUVAS). Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002; 62: 1732-42.
10. Pettersson EE, Sundelin B, Heigl Z. Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin. Nephrol. 1995; 43: 141-9.
11. Geffriaud-Ricouard C, Noel LH, Chauveau D, Houhou S, Grunfeld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin. Nephrol. 1993; 39: 125-36.
12. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J. Am. Soc. Nephrol. 1998; 9: 842-52.
13. Hedger N, Stevens J, Drey N, Walker S, Roderick P. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: A 10-year retrospective study. Nephrol. Dial. Transplant. 2000; 15: 1593-9.
14. Lee S, Lawton JW. Heterogeneity of anti-PR3 associated disease Hong Kong. Postgrad. Med. J. 2000; 76: 287-8.
15. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990; 33: 1101-7.
16. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitis. Proposal of an International Consensus Conference. Arthritis Rheum. 1994; 37: 187-92.
17. Steward J. The patient with proteinuria and/or haematuria. In: Davison A, ed. Oxford Textbook of Clinical Nephrology, 2nd edn. New York: Oxford, 1998; 441-59.
18. Richard J. Haematuria and proteinuria. In: Arthur G, ed. Primer on Kidney Diseases, 3rd edn. New York: National Kidney Foundation, 2001; 38-42.
19. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
20. Savage COS, Wineals CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: Presentation, pathology and prognosis. Q. J. Med. 1985; 220: 467-83.
21. Vizjak A, Rott T, Koselj-Kajtna M et al. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am. J. Kidney Dis. 2003; 41: 539-49.
22. Lim LCL, Taylor III JG, Schmitz JL et al. Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology. Am. J. Clin. Pathol. 1999; 111: 363-9.
23. Hagen EC, Daha MR, Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 1998; 53: 743-53.
24. Lisa A, Daniel H, Ellison L, Robert A, Jeffrey N, Robert H. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis. Arch. Intern. Med. 2002; 162: 1509-14.
25. D'Amico G, Sinico RA, Ferrario F. Renal vasculitis. Nephrol. Dial. Transplant. 1996; 11 (Suppl. 9): 69-74.
26. Angangco R, Thiru S, Esnault VL, Short AK, Lockwood CM, Olireira DB. Dose truly 'idiopathic' crescentic glomerulonephritis exist? Nephrol. Dial. Transplant. 1994; 9: 630-6.
27. Jennette JC, Falk RJ. Small vessel vasculitis. N. Engl. J. Med. 1997; 337: 1512-23.
28. Panegyres PK, Blumbergs PC, Leong AS, Bourne A. Vasculitis of peripheral nerve and skeletal muscle: Clinicopathological correlation and immunopathic mechanisms. J. Neurol. Sci. 1990; 100: 193-202.
29. Kissel JT, Mendell JR. Vasculitic neuropathy. Neurol. Clin. 1992; 10: 761-81.
30. Petersdorf RG, Beeson PB. Fever of unexplained origin: Report on 100 cases. Medicine (Baltimore) 1961; 40: 1-30.
31. Allen NB, Bressler PB. Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes. Med. Clin. North Am. 1997; 81: 243-59.
32. Cunha BA. Fever of unknown origin. Infect. Dis. Clin. North Am. 1996; 10: 111-27.